Delivery Order SPE2DR25D3103-SPE2DR26F9L16
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Yonsa (abiraterone acetate) 125 mg tablets in a quantity of 120 units, with a ceiling value of $2,393.67. The order is scheduled for ultimate completion by December 26, 2025, and utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.67 to AmerisourceBergen Drug Corp for the supply of Yonsa (abiraterone acetate) 125 mg tablets in a quantity of 120 units. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The order is scheduled for completion by December 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Yonsa 125 mg tablets (120 count) with a ceiling value of $4,787.34. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The order is scheduled for completion by January 5, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order for YONSA 125 MG tablets (120-count) valued at $4,542.74 by the Medical Supply Chain, a defense-focused federal agency, with an award date of September 3, 2025 and ultimate completion date of September 24, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Yonsa 125 mg tablets (120-count package) valued at $2,271.36 with a firm fixed price structure. This delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through...
- AmerisourceBergen Drug Corp received a $2,271.36 delivery order from the Defense Logistics Agency (DLA) on May 13, 2025, for the supply of YONSA 125 mg tablets (120-count units). The contract is classified as a firm fixed price delivery order with an ultimate completion date of June 4, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside procurement awarded through competitive means, consistent with...
- The Defense Logistics Agency awarded a $4,787.34 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Yonsa 125 mg tablets (120-count). This is a non-set-aside, competitively awarded contract with firm fixed pricing and a completion date of December 19, 2025. The pharmaceutical will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,542.74 to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count supply). The contract is firm fixed price with no set-aside designation and is scheduled for completion by August 15, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Yonsa 125 mg tablets (120 count) with a firm fixed price of $2,271.36 and an ultimate completion date of October 16, 2025. This is a competitively awarded, non-set-aside delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency awarded a $2,393.67 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Yonsa 125 mg tablets (120-count units). This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of January 2, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9L16Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of YONSA (abiraterone acetate) 125 mg tablets in a quantity of 120 units, with a contract value of $4,787.34. This firm fixed-price delivery order, issued on December 2, 2025, with an ultimate completion date of December 23, 2025, is classified as non-set-aside and represents a competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive delivery of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. Through the SPE2DX IDC, AmerisourceBergen supplies medical commodities to customers including the Defense Health Agency and U.S. Coast Guard. This YONSA delivery order exemplifies the company's role in providing specialized oncology pharmaceuticals to support federal healthcare requirements within the broader Defense Logistics Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 12/1/25 |